1. Home
  2. GETY vs TNXP Comparison

GETY vs TNXP Comparison

Compare GETY & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Getty Images Holdings Inc.

GETY

Getty Images Holdings Inc.

HOLD

Current Price

$0.26

Market Cap

183.0M

Sector

Industrials

ML Signal

HOLD

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

HOLD

Current Price

$11.87

Market Cap

199.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GETY
TNXP
Founded
1995
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
183.0M
199.7M
IPO Year
2022
2008

Fundamental Metrics

Financial Performance
Metric
GETY
TNXP
Price
$0.26
$11.87
Analyst Decision
Hold
Analyst Count
3
0
Target Price
$3.78
N/A
AVG Volume (30 Days)
2.7M
419.2K
Earning Date
05-11-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
91.75
EPS
N/A
N/A
Revenue
$926,244,000.00
$13,107,000.00
Revenue This Year
$0.37
$558.11
Revenue Next Year
$1.47
$38.29
P/E Ratio
N/A
N/A
Revenue Growth
0.82
29.85
52 Week Low
$0.23
$9.40
52 Week High
$3.21
$29.19

Technical Indicators

Market Signals
Indicator
GETY
TNXP
Relative Strength Index (RSI) 39.40 44.02
Support Level $0.23 $11.98
Resistance Level $0.29 $13.18
Average True Range (ATR) 0.02 0.68
MACD 0.01 -0.15
Stochastic Oscillator 68.10 1.80

Price Performance

Historical Comparison
GETY
TNXP

About GETY Getty Images Holdings Inc.

Getty Images Holdings Inc. is a visual content creator and marketplace that offers a full range of content solutions. Through its Getty Images, Stock, and Unsplash brands, websites, and APIs, it serves customers around the world by allowing them to discover, purchase, and share visual content from photographers, illustrators, image partners, and videographers. The company generates a majority of its revenue through subscriptions, offering various subscription products on the Getty Images, iStock, and Unsplash websites. It operates and manages one operating segment, which is the business of developing and commercializing visual content. Geographically, the company generates maximum revenue from the Americas, followed by Europe, the Middle East and Africa, and the Asia-Pacific region.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

Share on Social Networks: